Roadmap for America's Cancer Explorers for the 21st Century (Race 21)

21 世纪美国癌症探索者路线图(第 21 场比赛)

基本信息

  • 批准号:
    10478045
  • 负责人:
  • 金额:
    $ 41.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-03 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Roadmap for America’s Cancer Explorers for the 21st Century (RACE21) is an interdisciplinary program to develop a pipeline to a diverse 21st century cancer research workforce. Cancer is a primary cause of adult mortalities in the US, despite excellent advances in understanding cancer biology and innovative treatments. In Alabama, cancer is the 2nd highest cause of mortality, and cancer death rates are almost double in Alabama’s African-American (compared to White) males. One of the underlying causes of this anomaly is the lack of communication about cancer among Africa-Americans, especially within families. Also, relatively few African-American youth are seeking careers in cancer research, largely due to very little exposure to cancer biology in most of their secondary schools and their teachers’ lack of cancer biology training. Further, few informal programs excite students about careers in cancer biology. RACE21 will build an innovative and effective pipeline to cancer research careers, especially for students underrepresented in cancer research (URM) by building on 5-basic foundations: 1) The University of Alabama at Birmingham’s (UAB) outstanding O’Neal Comprehensive Cancer Center, 2) Over 200 cancer researchers, eager to mentor high school and college students to become the next generation of cancer researchers, 3) development of an innovative Undergraduate Cancer Biology Major, 4) the Center for Community OutReach Development (CORD), which will train high school biology teachers in cancer research and introduce advanced high school students to cancer research in both formal and informal settings and 5) training in communication about cancer. RACE21 employs successful methods developed at UAB, and uses them to advance cancer biology education. The pipeline starts with high school students being introduced to cancer biology through state-of-the-art experiences in the Summer Science Institute (10 URM rising seniors will be Summer Research Interns) and experiences at the GENEius lab. RACE21 will also provide intense cancer biology training to high school teachers via an annual 3-week BioTeach-Cancer training. RACE21 students (>80% URM) entering UAB’s new Cancer Biology Major will complete a paid summer internship in cancer research in their rising year 1 and 2, and in year 3 and 4 they will receive fellowships as cancer researchers. Each year 10 RACE21 students will complete the undergraduate major, with most continuing to graduate school in cancer research related areas. The Intellectual Merit of RACE21 will be in testing a pipeline that leads to increased minorities in cancer biology careers. The Broader Impacts will annually educate about 6,000 minority students, families and the public about cancer biology and launch the cancer research careers of >40 minority students.
21世纪美国癌症探索路线图(RACE21)是一个跨学科的项目

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lalita A. Shevde其他文献

Multi-faceted role of HSP40 in cancer
  • DOI:
    10.1007/s10585-009-9255-x
  • 发表时间:
    2009-04-02
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Aparna Mitra;Lalita A. Shevde;Rajeev S. Samant
  • 通讯作者:
    Rajeev S. Samant
Emerging role of nuclear protein 1 (NUPR1) in cancer biology
  • DOI:
    10.1007/s10555-009-9183-x
  • 发表时间:
    2009-01-20
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Uttio Roy Chowdhury;Rajeev S. Samant;Oystein Fodstad;Lalita A. Shevde
  • 通讯作者:
    Lalita A. Shevde
Informing the new developments and future of cancer immunotherapy
  • DOI:
    10.1007/s10555-021-09967-1
  • 发表时间:
    2021-05-18
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Atul Kumar;Courtney A. Swain;Lalita A. Shevde
  • 通讯作者:
    Lalita A. Shevde
Erratum to: ‘Hedgehog signaling: modulation of cancer properties and tumor microenvironment’
  • DOI:
    10.1186/s12943-016-0522-6
  • 发表时间:
    2016-05-11
  • 期刊:
  • 影响因子:
    33.900
  • 作者:
    Ann Hanna;Lalita A. Shevde
  • 通讯作者:
    Lalita A. Shevde
The metastatic cascade through the lens of therapeutic inhibition
通过治疗性抑制视角看转移级联
  • DOI:
    10.1016/j.xcrm.2024.101872
  • 发表时间:
    2025-01-21
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Ian Miranda;Nusrat Jahan;Lalita A. Shevde
  • 通讯作者:
    Lalita A. Shevde

Lalita A. Shevde的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lalita A. Shevde', 18)}}的其他基金

Role of O-GlcNAc-ylation on tumor progression
O-GlcNAc 基化在肿瘤进展中的作用
  • 批准号:
    10589810
  • 财政年份:
    2022
  • 资助金额:
    $ 41.79万
  • 项目类别:
Role of O-GlcNAc-ylation on tumor progression
O-GlcNAc 基化在肿瘤进展中的作用
  • 批准号:
    10444126
  • 财政年份:
    2022
  • 资助金额:
    $ 41.79万
  • 项目类别:
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)
21 世纪美国癌症探索者路线图(第 21 场比赛)
  • 批准号:
    10252847
  • 财政年份:
    2020
  • 资助金额:
    $ 41.79万
  • 项目类别:
Roadmap for America's Cancer Explorers for the 21st Century (Race 21)
21 世纪美国癌症探索者路线图(第 21 场比赛)
  • 批准号:
    10023708
  • 财政年份:
    2020
  • 资助金额:
    $ 41.79万
  • 项目类别:
Mechanisms of resistance to cancer therapeutics
癌症治疗的耐药机制
  • 批准号:
    8694974
  • 财政年份:
    2014
  • 资助金额:
    $ 41.79万
  • 项目类别:
Mechanisms of resistance to cancer therapeutics
癌症治疗的耐药机制
  • 批准号:
    8830937
  • 财政年份:
    2014
  • 资助金额:
    $ 41.79万
  • 项目类别:
Mechanisms of resistance to cancer therapeutics
癌症治疗的耐药机制
  • 批准号:
    9079414
  • 财政年份:
    2014
  • 资助金额:
    $ 41.79万
  • 项目类别:
Molecular determinants of breast cancer malignancy
乳腺癌恶性肿瘤的分子决定因素
  • 批准号:
    8458999
  • 财政年份:
    2011
  • 资助金额:
    $ 41.79万
  • 项目类别:
Molecular determinants of breast cancer malignancy
乳腺癌恶性肿瘤的分子决定因素
  • 批准号:
    8653835
  • 财政年份:
    2011
  • 资助金额:
    $ 41.79万
  • 项目类别:
Molecular determinants of breast cancer malignancy
乳腺癌恶性肿瘤的分子决定因素
  • 批准号:
    8261842
  • 财政年份:
    2011
  • 资助金额:
    $ 41.79万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 41.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了